Elpis Pharmaceuticals Private Limited

Elpis Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U51507DL2013PTC261564 Incorporated 03 December 2013 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹97 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
Last financials
Mar 2024
Balance sheet date
Last AGM
30 Sep 2024
Annual general meeting
Company status
Active
MCA master data

About Elpis Pharmaceuticals Private Limited

Data last updated:

Elpis Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 December 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51507DL2013PTC261564. Its GSTIN is 07AADCE5607M1ZH (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹97 Lakh. It is led by directors Rohit Garg (Managing Director) and Pankaj Shukla.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D – 600 Basement Chittaranjan Park Opp. Ramanujan College Pops – Chittara, Njan Park., New Delhi, Delhi, India – 110019.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51507DL2013PTC261564
Registration Number 261564
Incorporation Date 03 December 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Elpis Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    D – 600 Basement Chittaranjan Park Opp. Ramanujan College Pops – Chittara, Njan Park., New Delhi, Delhi, India – 110019
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Elpis Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Elpis Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Elpis Pharmaceuticals Private Limited

FY 2024 filings available

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Elpis Pharmaceuticals Private Limited, buy the company report.

Board of directors of Elpis Pharmaceuticals Private Limited

Elpis Pharmaceuticals has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pankaj ShuklaDirector01 Sep 20251 Years 2 MonthsCurrent
Rohit GargManaging Director13 Nov 20178 Years 11 MonthsCurrent

Auditor

Elpis Pharmaceuticals Private Limited is audited by Deapak A Gupta & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Deapak A Gupta & AssociatesFY 2023037635N

Shareholding

The shareholding of Elpis Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Elpis Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Elpis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Elpis Pharmaceuticals has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AADCE5607M1ZHDelhiActive01 Jul 2017
06AADCE5607M1ZJHaryanaActive01 Sep 2019

To see the full GST registrations and return filing status of Elpis Pharmaceuticals Private Limited, buy the company report.

Recent activity

Elpis Pharmaceuticals Private Limited has 13 board changes on record since 2016: 3 appointments and 10 cessations. The latest: Pankaj Shukla was appointed as Director on 01 Sep 2025.

Appointed
Pankaj Shukla was appointed as Director.
Ceased
Gautam Garg ceased to be Additional Director.
AGM
Elpis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Elpis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi I.
Appointed
Gautam Garg was appointed as Director.
Ceased
Aditya Singh ceased to be Director.
Ceased
Somnath Ghosh ceased to be Additional Director.
Ceased
Adipta Majumder ceased to be Additional Director.
Ceased
Pankaj Shukla ceased to be Director.
Ceased
Rahul Kalra ceased to be Director.
Ceased
Aarti Menon ceased to be Director.
Ceased
Anshul Kalra ceased to be Director.

4 earlier events are in the company report.

Frequently asked questions

Elpis Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 December 2013 (13+ years old) and is registered under CIN U51507DL2013PTC261564.

Elpis Pharmaceuticals has 2 current directors:

The latest financial statements of Elpis Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Elpis Pharmaceuticals is 07AADCE5607M1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AADCE5607M1ZJ (Haryana).

The CIN (Corporate Identification Number) of Elpis Pharmaceuticals is U51507DL2013PTC261564. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Elpis Pharmaceuticals was incorporated on 03 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.

Pankaj Shukla was appointed as Director on 01 Sep 2025. Gautam Garg ceased to be Additional Director on 25 Nov 2024. Gautam Garg was appointed as Director on 09 May 2023. Elpis Pharmaceuticals has 13 board changes on record in total.

The registered office of Elpis Pharmaceuticals is at D – 600 Basement Chittaranjan Park Opp. Ramanujan College Pops – Chittara, Njan Park., New Delhi, Delhi, India – 110019.

Elpis Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

The compliance status of Elpis Pharmaceuticals is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.